Breast Augmentation Risks: Complete Clinical Guide (2026)

Breast augmentation is one of the most studied cosmetic procedures in modern surgery, with patient satisfaction rates of 85–90% at five-year follow-up [5]. It is also a procedure with well-documented complications — some minor, some serious, and a small handful with lifelong implications. Anyone considering implants deserves the full picture, not a marketing summary. This guide breaks down every meaningful risk associated with breast augmentation: short-term surgical complications, long-term implant-related issues, the rare but real risk of BIA-ALCL, the contested topic of breast implant illness, and the lifetime reality that most implants will eventually require a second surgery.

Quick overview

Breast augmentation is generally safe when performed by a board-certified plastic surgeon in an accredited facility, but it is not risk-free. Roughly one in five patients will need revision surgery within ten years [3], and a meaningful percentage will experience some form of complication — most commonly capsular contracture, implant malposition, or changes in nipple sensation.

The most serious risks (death from anesthesia, pulmonary embolism, BIA-ALCL) are rare, occurring in well under 1% of cases [1][7]. The more common risks (capsular contracture, rippling, asymmetry, need for revision) are not life-threatening but are frequent enough that any honest consent discussion treats them as expected possibilities rather than rare events.

The risk profile is not uniform. Implant type, placement, surgical technique, patient anatomy, smoking status, and surgeon experience all shift the probability of complications. Understanding which risks apply most to a given patient is more useful than memorizing a generic list.

Short-term surgical complications

The first six weeks after surgery carry the highest density of complications. Most are manageable; a few require return to the operating room.

Infection

Infection occurs in 1–3% of primary breast augmentations [3]. Superficial infections respond to oral antibiotics. Deeper infections involving the implant pocket are more serious and may require implant removal, a course of IV antibiotics, and delayed reinsertion months later. Staphylococcus species — including MRSA — are the most common culprits. Diabetes, smoking, and immunosuppression raise the risk.

Hematoma and seroma

Hematoma (a collection of blood) and seroma (a collection of clear fluid) occur in 1–5% of cases [3]. Hematomas usually appear within the first 24–48 hours and present as rapid, asymmetric swelling and pain; they typically require surgical drainage. Seromas develop more slowly, occur in 2–5% of cases [7], and may resolve on their own or require needle aspiration.

Anesthesia and thromboembolism

General anesthesia complications occur in less than 1% of breast augmentations [7]. Pulmonary embolism — a blood clot traveling to the lungs — is estimated at 0.1–0.2% [7]. Risk increases with obesity, prolonged operative time, hormonal contraceptives, and a personal or family history of clotting disorders. Early ambulation and, in selected patients, mechanical or chemical prophylaxis reduce this risk.

Changes in nipple and breast sensation

Temporary or permanent numbness affects 15–30% of patients [4]. Most sensory changes resolve within 6–12 months, but a subset are permanent. Larger implants, periareolar (around-the-nipple) incisions, and aggressive pocket dissection increase the risk. Loss of erotic sensation and loss of the ability to breastfeed are documented but variable outcomes that warrant explicit discussion before surgery.

Long-term implant-related complications

Breast implants are medical devices, not permanent installations. The longer they remain in place, the higher the cumulative probability of a complication that requires intervention.

Capsular contracture

The body forms a scar tissue capsule around every implant. In 10–15% of primary augmentations, that capsule tightens, thickens, and distorts the breast [2]. Mild cases (Baker grade I–II) are cosmetic only. Severe cases (Baker grade III–IV) cause firmness, pain, and visible distortion, and require capsulectomy — removal of the scar tissue, often with implant exchange.

Risk factors include subglandular (above-muscle) placement, bacterial biofilm on the implant surface, hematoma, and radiation exposure. Submuscular placement and meticulous sterile technique reduce — but do not eliminate — the risk. For a deeper comparison, see the clinical breakdown of above-muscle versus below-muscle placement.

Implant rupture and deflation

Saline implant rupture rates are approximately 1% per year, with rapid, obvious deflation [4]. Silicone gel ruptures are often "silent" — the cohesive gel stays largely contained within the capsule, producing no visible change [4]. The FDA recommends MRI or high-resolution ultrasound screening for silent rupture beginning five to six years after silicone implantation and every two to three years thereafter [2].

Form-stable ("gummy bear") implants are designed to resist gel migration even when the shell fails. The trade-offs are covered in TrustClinic's gummy bear implants clinical guide.

Malposition, rippling, and palpability

Implant displacement or malposition occurs in 5–10% of augmentations [5]. Common patterns include bottoming-out (implant settling too low), lateral displacement (implant drifting toward the armpit), and symmastia (implants meeting in the middle). Rippling and palpability — being able to see or feel implant edges — are more common with saline implants and in thin patients with little soft tissue coverage [5].

Revision surgery

Approximately 20–25% of patients require revision surgery within ten years of primary augmentation [3]. The most common reasons are capsular contracture, rupture, malposition, size change, and aesthetic refinement as the breast and body change over time. Revision surgery is typically more expensive, more technically demanding, and carries higher complication rates than primary augmentation. The lifetime cost implications are explored in TrustClinic's analysis of the true lifetime price of breast implants.

BIA-ALCL: a rare but serious cancer

Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) is a type of non-Hodgkin lymphoma that develops in the scar capsule around textured breast implants. It is not breast cancer.

Incidence estimates range from 1 in 3,000 to 1 in 30,000 textured implants [1]. The median time from implantation to diagnosis is 8–10 years [1]. The FDA requires a boxed warning on all breast implant packaging regarding BIA-ALCL risk [2], and several manufacturers have voluntarily recalled specific textured implant lines.

Most cases present as delayed seroma — late-onset swelling of one breast, often years after surgery. When caught early and confined to the capsule, BIA-ALCL is generally curable with complete capsulectomy and implant removal. Advanced cases may require chemotherapy.

Practical implications:

• Smooth-surface implants carry significantly lower BIA-ALCL risk than textured implants [1]
• Any late-onset swelling, fluid collection, or mass around an implant warrants prompt evaluation
• Patients with textured implants should not panic — the absolute risk remains low — but should be aware of symptoms and maintain follow-up

Breast implant illness (BII)

Breast implant illness is a constellation of self-reported systemic symptoms — fatigue, joint pain, brain fog, hair loss, autoimmune-like symptoms — that some patients attribute to their implants [6].

The scientific picture is unresolved. BII has no established diagnostic criteria, no validated biomarker, and no proven causal mechanism linking implants to systemic disease [6]. Large epidemiologic studies have not consistently demonstrated an increased rate of defined autoimmune diseases in implant patients. At the same time, a subset of patients reports meaningful symptom improvement after explantation, and the FDA acknowledges patient reports as part of ongoing surveillance [2].

The honest framing: BII is a real patient experience whose biological basis is not yet understood. Patients considering augmentation should be informed that some women report systemic symptoms they attribute to implants, that explantation sometimes improves symptoms, and that the evidence base is still evolving [6].

Risk stratification: who faces higher complication rates

Not every patient carries the same risk. Several factors meaningfully shift the probability of complications:

Higher-risk profiles:

• Smokers: impaired wound healing, higher infection and capsular contracture rates
• BMI above 30: higher anesthesia, thromboembolism, and wound healing risk
• Diabetes (especially uncontrolled): higher infection risk
• Connective tissue or autoimmune disease: unclear but potentially elevated risk for BII-type symptoms
• History of radiation to the chest: dramatically higher capsular contracture and wound complication rates
• Very thin patients with minimal soft tissue: higher rippling, palpability, and malposition rates
• Patients seeking very large implants (>400cc) relative to their frame: higher rates of bottoming out, thinning tissue, and revision

Lower-risk profiles:

• Non-smoker, healthy BMI, no significant comorbidities
• Adequate native breast tissue for soft-tissue coverage
• Realistic size expectations matched to body frame
• Submuscular placement with smooth-surface implants in primary augmentation

Implant size and shape selection is one of the most controllable risk variables. TrustClinic's decision framework for implant size discusses how sizing affects long-term tissue outcomes.

Silicone vs. saline: risk differences

Both implant types are FDA-approved and considered safe, but they fail differently and carry different aesthetic risk profiles [4][5].

Saline implants:

• Rupture is immediately obvious (visible deflation)
• Saline is harmlessly absorbed by the body
• Higher rates of rippling and palpability, especially in thin patients
• Slightly firmer feel

Silicone gel implants:

• Rupture may be silent and require imaging to detect
• Require periodic MRI or ultrasound screening per FDA guidance [2]
• More natural feel and lower rippling rates
• Form-stable (cohesive) versions resist gel migration

A detailed side-by-side analysis is available in TrustClinic's silicone vs. saline clinical comparison.

Reducing risk: what is actually within the patient's control

Most complication rates cited in this article come from mixed populations including high-volume surgeons, low-volume surgeons, and accredited and non-accredited facilities. Patients have meaningful leverage over their individual risk.

Choose a properly credentialed surgeon

Board certification by the American Board of Plastic Surgery correlates with lower complication rates [8]. Board certification means the surgeon completed an accredited plastic surgery residency, passed written and oral examinations, and maintains continuing education. "Board-certified cosmetic surgeon" is not the same credential and may indicate training in another specialty.

Verify credentials directly through the ABPS at certificationmatters.org rather than trusting a clinic's website.

Operate in an accredited facility

Accredited surgical facilities (AAAASF, AAAHC, or hospital-based) have verified equipment, staffing, and emergency protocols. Office-based procedures performed in non-accredited rooms carry higher rates of serious adverse events.

Optimize health before surgery

• Stop smoking at least 4–6 weeks before and after surgery
• Control blood sugar if diabetic
• Reach a stable BMI under 30 when possible
• Disclose all medications and supplements, including hormonal contraceptives
• Address any active infections (dental, skin, urinary) before surgery

Follow surveillance recommendations

The FDA recommends imaging surveillance for silicone implants starting 5–6 years post-op and every 2–3 years thereafter [2]. Late-onset swelling, pain, firmness, or asymmetry at any point warrants evaluation.

Recovery timeline

Breast Augmentation — what to expect, week by week

Typical recovery 7–14 days before patients return to most normal activities.

1. Day 1–7
   Most pain & swelling. Compression garment 23 h/day. Walk daily.
2. Week 2
   Off prescription meds, light activity, swelling starts to drop.
3. Weeks 3–4
   Return to desk work. Light cardio. Sleep position may relax.
4. Weeks 5–8
   Resistance training cleared by most surgeons. Garment off.
5. Months 3–6
   Final shape emerges, swelling fully resolved, scars mature.

General guidance only. Your surgeon's instructions take precedence.

The honest verdict

Breast augmentation is a well-studied, generally safe procedure with high patient satisfaction [5]. It is also a lifetime commitment to a medical device that will, statistically, require additional surgery for most patients who live with implants for several decades [3].

The serious risks — BIA-ALCL, pulmonary embolism, anesthesia death — are rare. The common risks — capsular contracture, sensory changes, revision surgery, rippling, malposition — are frequent enough that an informed patient should treat them as part of the deal, not as freak occurrences. Breast implant illness remains scientifically unresolved but is taken seriously by the FDA and warrants honest disclosure during consent [2][6].

The patients who fare best are those who choose properly credentialed surgeons, accredited facilities, conservative implant sizing matched to their anatomy, and who maintain long-term follow-up. The patients who fare worst are typically those who chose surgeons based on price, traveled to unregulated facilities, or were not adequately informed about the lifetime trajectory of living with implants.

Reputable surgeons in major metropolitan markets — including breast augmentation specialists in Miami, Los Angeles, New York, and Houston — vary widely in technique, experience, and revision rates. Consultation with at least two board-certified plastic surgeons is a reasonable minimum before scheduling surgery. For full pricing context, see TrustClinic's breast augmentation cost guide.

This article is for educational purposes only and does not constitute medical advice. Surgical decisions should be made in consultation with a board-certified plastic surgeon who has evaluated the individual patient's anatomy, health history, and goals.